Mersch, Martin
Schlabe, Stefan
Breitschwerdt, Sven
Laufenberg, Judith
Emmert, Dorian
Aldabbagh, Souhaib
Boesecke, Christoph
Monin, Malte Benedikt http://orcid.org/0000-0002-8794-3612
Funding for this research was provided by:
Universitätsklinikum Bonn
Article History
Received: 16 September 2023
Accepted: 17 October 2023
First Online: 6 November 2023
Declarations
:
: MM declares no conflicts of interest. SS had a stipend from the German Centre for Infectious Diseases Research (DZIF); he received congress fees and travel expenses from Gilead, Abbvie, and Johnson&Johnson, and funding from the German Research Society (DFG) for initiation of an African-German research project; he holds Fonds-based shares from BionTech. SB declares no conflicts of interest. JL declares no conflicts of interest. DE received honoraria for lectures from Gilead and holds stocks from BionTech. SA declares no conflicts of interest. CB received honoraria for lectures and/or consultancies from AbbVie, Gilead, Janssen, MSD, ViiV, and funding from Dt. Leberstiftung, DFG, DZIF, Hector Stiftung, NEAT ID. MBM received honoraria for lectures, travel expenses, and/or consultancies from Pfizer, Gilead Sciences, AstraZen- eca, NovaVax, and Virology Education. However, these activities have no potential conflicts of interest with the manuscript.
: Due to the retrospective study design, ethical approval and/or patient information were not required according to the North Rhine-Westphalian legislation.
: The consent of the late patient's relatives was obtained.